Robert K. Doot, Ph.D.
Affiliations: | 2008 | University of Washington, Seattle, Seattle, WA |
Area:
Biomedical Engineering, RadiologyGoogle:
"Robert Doot"Parents
Sign in to add mentor| Paul Kinahan | grad student | 2008 | University of Washington | |
| (Factors affecting quantitative PET as a measure of cancer response to therapy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nabavizadeh A, Bagley SJ, Doot RK, et al. (2022) Distinguishing Progression from Pseudoprogression in Glioblastoma Using F-Fluciclovine PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
| Pantel AR, Gitto SB, Makvandi M, et al. (2022) [18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a pilot study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Doot RK, Young AJ, Nasrallah IM, et al. (2022) [F]NOS PET Brain Imaging Suggests Elevated Neuroinflammation in Idiopathic Parkinson's Disease. Cells. 11 |
| Pantel AR, Viswanath V, Muzi M, et al. (2022) Principles of Tracer Kinetic Analysis in Oncology, Part II: Examples and Future Directions. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 63: 514-521 |
| Pantel AR, Viswanath V, Muzi M, et al. (2022) Principles of Tracer Kinetic Analysis in Oncology, Part I: Principles and Overview of Methodology. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 63: 342-352 |
| Lee HS, Schwarz SW, Schubert EK, et al. (2022) The Development of F Fluorthanatrace: A PET Radiotracer for Imaging Poly (ADP-Ribose) Polymerase-1. Radiology. Imaging Cancer. 4: e210070 |
| Romine PE, Peterson LM, Kurland BF, et al. (2021) F-fluorodeoxyglucose (FDG) PET or F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study. Breast Cancer Research : Bcr. 23: 88 |
| McDonald ES, Pantel AR, Shah PD, et al. (2021) In vivo visualization of PARP inhibitor pharmacodynamics. Jci Insight. 6 |
| Young AJ, Pantel AR, Viswanath V, et al. (2021) Kinetic and static analysis of poly-(adenosine diphosphate-ribose) polymerase-1 (PARP-1) targeted F-FluorThanatrace (F-FTT) PET images of ovarian cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
| Viswanath V, Zhou R, Lee H, et al. (2020) Kinetic Modeling of F-(2S,4R)4-Fluoroglutamine in Mouse Models of Breast Cancer to Estimate Glutamine Pool Size as an Indicator of Tumor Glutamine Metabolism. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |